0.4497
price down icon2.22%   -0.0102
after-market Handel nachbörslich: .46 0.0103 +2.29%
loading

Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
31.26%
1.39
1.059 1.412 1.456 1.279
Operating Expenses
36.28%
2.928
4.595 5.312 5.255 4.976
Benefits Costs and Expenses
-
- -13.49 4.33 4.219
Costs And Expenses
36.28%
2.928
4.595 5.312 5.255 4.976
Operating Income/Loss
56.50%
-1.538
-3.536 -3.90 -3.799 -3.697
Nonoperating Income/Loss
148.24%
6.689
-13.87 -0.003 0.925 0.757
Income/Loss From Continuing Operations Before Tax
107.99%
1.39
-17.40 14.90 -2.874 -2.94
Income/Loss From Continuing Operations After Tax
129.60%
5.151
-17.40 -3.903 -2.874 -2.94
Net Income/Loss
129.60%
5.151
-17.40 -3.903 -2.874 -2.94
Preferred Stock Dividends And Other Adjustments
3.96
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
232.19%
48.39
14.57 0.4081 7.8558 6.5008
Diluted Average Shares
1,336%
209.15
14.57 -0.7516 7.8558 10.74
Basic Earnings Per Share
101.68%
0.02
-1.19 -0.49 -0.37 -0.45
Diluted Earnings Per Share
99.16%
-0.01
-1.19 -0.67 -0.37 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
3.96
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):